BioVie, Inc. (BIVI)
2.16
-0.03
(-1.37%)
USD |
NASDAQ |
Aug 28, 16:00
2.17
+0.01
(+0.46%)
After-Hours: 20:00
BioVie Price to Book Value : 1.586 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.586 |
| August 27, 2026 | 1.608 |
| August 26, 2026 | 1.550 |
| August 25, 2026 | 1.535 |
| August 24, 2026 | 1.572 |
| August 21, 2026 | 1.432 |
| August 20, 2026 | 1.366 |
| August 19, 2026 | 0.9841 |
| August 18, 2026 | 0.7083 |
| August 17, 2026 | 0.8593 |
| August 14, 2026 | 1.028 |
| August 13, 2026 | 1.146 |
| August 12, 2026 | 1.146 |
| August 11, 2026 | 0.9327 |
| August 10, 2026 | 0.8078 |
| August 07, 2026 | 0.7339 |
| August 06, 2026 | 0.9915 |
| August 05, 2026 | 1.498 |
| August 04, 2026 | 1.344 |
| August 03, 2026 | 1.190 |
| July 31, 2026 | 1.116 |
| July 30, 2026 | 1.050 |
| July 29, 2026 | 0.9254 |
| July 28, 2026 | 0.9768 |
| July 27, 2026 | 1.006 |
| Date | Value |
|---|---|
| July 24, 2026 | 1.006 |
| July 23, 2026 | 1.058 |
| July 22, 2026 | 0.9841 |
| July 21, 2026 | 0.9474 |
| July 20, 2026 | 1.046 |
| July 17, 2026 | 1.322 |
| July 16, 2026 | 1.263 |
| July 15, 2026 | 1.300 |
| July 14, 2026 | 1.160 |
| July 13, 2026 | 1.204 |
| July 10, 2026 | 1.667 |
| July 09, 2026 | 1.645 |
| July 08, 2026 | 1.601 |
| July 07, 2026 | 1.586 |
| July 06, 2026 | 1.542 |
| July 02, 2026 | 1.432 |
| July 01, 2026 | 1.601 |
| June 30, 2026 | 1.425 |
| June 29, 2026 | 0.9713 |
| June 26, 2026 | 0.9374 |
| June 25, 2026 | 0.8601 |
| June 24, 2026 | 0.9278 |
| June 23, 2026 | 0.9374 |
| June 22, 2026 | 0.9374 |
| June 18, 2026 | 0.8505 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.00 |
| Anika Therapeutics, Inc. | 2.057 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.782 |
Price to Book Value Related Metrics
| Price | 2.16 |
| Earnings Yield | -148.0% |
| Market Cap | 16.29M |